Skip to main content
. Author manuscript; available in PMC: 2009 Dec 21.
Published in final edited form as: Transplant Proc. 2009 Mar;41(2):539–541. doi: 10.1016/j.transproceed.2009.01.015

Table 1.

Experimental Groups and Skin Transplant Survival

Group No. Animal No. Haplotype Mismatch 1°/2° Skin Transplant HSC Engraftment Skin Survival (Postoperative Day)
1 13476 CD→AD Yes Rejected (d55)
16626 AC→AD * Yes Rejected (d64)
2 17468 AC→AD Yes Survival (>d46)
17469 AC→AD Yes Survival (>d300)
3 17476 DD→AC No Rejected (d8)
17506 DD→AC No Rejected (d7)
4 17519 AC→AD No Rejected (d6)
17520 AC→AD * No Rejected (d6)
*

Topical 0.1% FK506 ointment applied daily in attempt to delay rejection.

1° refers to primarily vascularized skin flap; 2° refers to skin grafts that are secondarily vascularized after placement.